Clinical Trial Update: Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCC [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial is evaluating neoadjuvant immunotherapy plus chemoradiation versus neoadjuvant chemoradiation for locally advanced, resectable esopha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Esophageal Squamous Cell Carcinoma Stage II, Esophageal Squamous Cell Carcinoma Stage III | Phase 2, Phase 3 | Status: RECRUITING